Arizona SB1797 prohibits price gouging on essential off-patent or generic drugs.
Arizona SB1797 amends the Arizona Revised Statutes to add a chapter on prescription drugs, specifically targeting price gouging on essential off-patent or generic drugs. The bill defines essential off-patent or generic drugs as those that are crucial for treating serious health conditions, have limited manufacturers, and are available in Arizona. It prohibits manufacturers and wholesale distributors from engaging in price gouging, which is defined as an excessive and unjustified price increase.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.